Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture
about
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyNovel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitroThe valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance.RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy.A mutation at position 190 of human immunodeficiency virus type 1 reverse transcriptase interacts with mutations at positions 74 and 75 via the template primerClinically relevant genotype interpretation of resistance to didanosineEfficacy of antiretroviral agents against murine replication-competent retrovirus infection in human cells.Genotypic testing for human immunodeficiency virus type 1 drug resistance.Incidence and impact of resistance against approved antiretroviral drugs.Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agentA novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcriptionMutants of feline immunodeficiency virus resistant to 2',3'-dideoxy-2',3'-didehydrothymidine.Antiviral therapy for human immunodeficiency virus infectionsA Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy.Bifunctional inhibition of HIV-1 reverse transcriptase: a first step in designing a bifunctional triphosphate.HIV-1 drug resistance mutations: an updated framework for the second decade of HAARTHIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillanceThe Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses.Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates.Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine.Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapy.Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structure.Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice.Stavudine:pharmacology,clinical use and future role.Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibilityReverse transcriptase genotype and antiretroviral susceptibility of human immunodeficiency virus isolates from patients with advanced disease treated with didanosine: correlation with virologic response and survival.Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.Prevalence of the mutational pattern E44D/A and/or V118I in the reverse transcriptase (RT) gene of HIV-1 in relation to treatment with nucleoside analogue RT inhibitors.Mechanistic studies to understand the progressive development of resistance in human immunodeficiency virus type 1 reverse transcriptase to abacavir.
P2860
Q24684152-6746556F-083B-42DF-94AC-8DEF1BF0A5CAQ28379249-8F5D5DB8-4702-48BF-956D-0A9F20037892Q31779475-89EE2552-3670-46AE-8C5D-5951DCC23BFAQ33514943-72A74187-FCCC-4C2B-8041-D195428C4638Q33690164-8BA99A07-EA22-40EE-A44C-393911A4EA17Q33770146-D4A16925-9500-4E21-B452-DF4964BF3AD5Q33821343-E47BA41C-BE61-46B0-89F9-40DDB83AE5A7Q33906239-979D938E-6E32-44FA-98EA-7AE819E1B835Q33966248-5B1965DB-5D72-4CA8-BEDE-107AFDA325F2Q33987492-F608E81C-A450-400F-A11B-53AA419B6652Q34110204-35B626C0-A82E-4447-AE23-ECE3CE8A60CFQ34113812-7E58B7EA-ECEE-43DE-990D-ADD25C3A97F2Q34976902-E7D91D61-BBBA-40C7-8BA1-7A7722BF0E57Q35122784-BC4D5745-CBBC-4FD6-802C-18BE35C899AEQ35126454-383E863E-C979-4C0C-A274-351110FAC01DQ35366050-6030812F-BE51-4D9F-87BE-A47728D671F4Q35742512-021CB239-2CE4-44C3-A0A4-DD06564AB10EQ35828466-8601FC8F-D9A5-4BAD-8F5F-520249374A9EQ36634319-A1B72F7D-3538-4F0C-9BFC-7ACC6EC87F35Q36900010-5D9D65F6-E1C0-4D08-A106-F267F909EAA7Q37003252-CA8A1D9F-2825-47A2-B020-1327345CF07FQ37018369-8C09D6DC-83E7-4489-BE3B-5B12CF2F8258Q37372064-1660B6BC-D3FE-4064-AEF2-AF3774232143Q37387866-94B86406-EE87-4B25-A3D8-56CC763A9F1BQ37432131-5F08F29F-97AF-472C-BB67-78793A0D6093Q38290579-47E780BD-16CA-4B4E-A8C8-689D8C054629Q39471491-A599A0C2-14F6-46CA-9BAE-3996E58100CDQ39475754-4F5A2776-2ED2-40C9-85C3-A552A70827DFQ39475801-00C825CA-1E84-4D32-BA92-26EF47741BAEQ39477865-DE7CF08E-EB2E-43D7-9C1C-FEA36245018CQ39557921-FAF5FA69-2955-43D9-9949-7A308C3010ACQ39603905-3518AD7A-F12A-4B4E-B39B-0EFCAC0EED40Q39912641-3B9F8640-3F55-4F3F-B0A9-5109CF56FFD1Q40884087-F8024137-B133-456E-8F83-B244375BADD5Q40904055-0EB38FA5-E009-4768-A2D0-EE03B77DCFC6Q42151695-53784C17-1724-42B0-BA59-D97260C9E91AQ43413064-77672125-1C29-4802-B5A1-EE2229B56E66Q43818113-BF8457FA-D95D-4CE1-9837-68F7F5216788Q43856149-CA08F3F3-C5EB-44EA-B2FE-C50451B3C7DCQ44102100-CE7E82D5-BA47-4694-9882-64D482A36EAA
P2860
Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@ast
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@en
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@nl
type
label
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@ast
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@en
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@nl
prefLabel
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@ast
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@en
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@nl
P2860
P356
P1476
Novel mutation (V75T) in human ...... deoxythymidine in cell culture
@en
P2093
P2860
P304
P356
10.1128/AAC.38.6.1428
P407
P577
1994-06-01T00:00:00Z